Fig. 1From: Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic markerCD26 serum levels in patients with gastric cancer (n = 30) and in control healthy individuals (n = 24). Patients serum CD26 levels: 557.7 ± 118.3 pg/mL; control serum CD26 levels: 703.4 ± 170.3 pg/mL. *p = 0.001 by unpaired t testBack to article page